Basic Information
| LncRNA/CircRNA Name | MIR100HG |
| Synonyms | NA |
| Region | GRCh38_11:122028327-122556721 |
| Ensemble | ENSG00000255248 |
| Refseq | NR_024430 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | gastric cancer cell lines and tissues |
| Expression Pattern | up-regulated |
| Function Description | In our study, we first found levels of MIR100HG expression were increased in gastric cancer cell lines and tissue samples compared with normal gastric epithelial cell line and adjacent normal gastric mucosa tissue samples, |
| Pubmed ID | 30886062 |
| Year | 2019 |
| Title | MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer. |
External Links
| Links for MIR100HG | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |